Screener
Corcept Therapeutics CORT Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Corcept Therapeutics’s reported figures.
The source filing: Corcept Therapeutics’s 10-Q, filed July 29, 2026. Open the filing →
- Filed
- Jul 29, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050613
FAQ
- What is Corcept Therapeutics's enterprise value?
- Corcept Therapeutics (CORT) reported enterprise value of $9.23B in Q2 2026.
- How has Corcept Therapeutics's enterprise value changed year-over-year?
- Corcept Therapeutics's enterprise value increased by 14.7% year-over-year, from $8.04B to $9.23B.
- What is the long-term trend for Corcept Therapeutics's enterprise value?
- Over 5 years (2020 to 2025), Corcept Therapeutics's enterprise value has grown at a 3.8% compound annual growth rate (CAGR), from $2.95B to $3.54B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Corcept Therapeutics's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude